Stockreport

Oruka Therapeutics price target raised to $85 from $45 at Wedbush [Yahoo! Finance]

Oruka Therapeutics, Inc.  (ORKA) 
PDF The firm reviewed anticipated benchmarks and stock setup for upcoming induction data from the Phase 2a EVERLAST-A trial of ORKA-001 for psoriasis. Wedbush speculates a d [Read more]